Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 (without DAC) Overview, Dosing & Safety | Peptide Database

CJC-1295 (without DAC) is a ghrh analog. studied for preserves natural gh pulsatility and minimal side effects. Half-life: 30 minutes - 2 hours. Dosing, safe...

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

CJC-1295 (without DAC) (Modified GRF 1-29)

Short-Acting Growth Hormone Releasing Hormone Analog

Community Research

Join others researching CJC-1295 (without DAC) — share findings, ask questions, and learn from real experiences

Synthetic growth hormone releasing hormone analog with short half-life enabling pulsatile GH secretion patterns resembling natural physiology. Unlike CJC-1295 with DAC, this version preserves natural GH pulsatility without continuous elevation.

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Molecular Data

Tyrosine

Position 1

Alanine

Position 2

Aspartic Acid

Position 3

Position 4

Isoleucine

Position 5

Phenylalanine

Position 6

Threonine

Position 7

Asparagine

Position 8

Serine

Position 9

Position 10

Arginine

Position 11

Lysine

Position 12

Valine

Position 13

Leucine

Position 14

Position 15

Glutamine

Position 16

Position 17

Position 18

Position 19

Position 20

Position 21

Position 22

Position 23

Position 24

Position 25

Position 26

Position 27

Position 28

Position 29

Position 30

Research Indications

Restores natural GH pulsatility patterns in aging individuals.

Elevates IGF-1 through enhanced GH secretion.

Supports pituitary axis without suppression of natural function.

Supports maintenance of lean muscle mass through GH elevation.

Supports bone health through GH-mediated pathways.

Improvements in skin quality through collagen synthesis.

Enhanced recovery from training through GH elevation.

Improved sleep architecture with bedtime dosing.

Dosing Protocols

Subcutaneous injection is the only effective route. Best administered on empty stomach, 30+ minutes away from food.

Anti-Aging/Wellness

100mcg

2x daily (morning and bedtime)

SubQ

Body Composition

100-150mcg

3x daily (morning, post-workout, bedtime)

Maximum GH Release

200mcg

2-3x daily with GHRP

Sleep Enhancement

100-200mcg

Once at bedtime

Reconstitution Instructions

Bacteriostatic water

Insulin syringes (29-31 gauge)

Alcohol swabs

Sterile work surface

1 Clean vial tops with alcohol pad and allow to dry

2 Draw bacteriostatic water slowly

3 Inject water along vial side

4 Gently roll to mix—avoid vigorous shaking

5 Verify solution clarity; cloudiness indicates degradation

6 Label with date and concentration

7 Refrigerate immediately, use within 30 days

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Generally well-tolerated at recommended doses

Temporary facial flushing/warmth (5-10 minutes post-injection)

Stop Signs - Discontinue if:

Persistent joint pain or carpal tunnel symptoms

Significant water retention or edema

Unexplained headaches or vision changes

Extreme fatigue or lethargy

Allergic reaction signs at injection sites

Contraindications

Active cancer (due to growth-promoting effects)

Diabetic retinopathy

Severe kidney disease

Pregnancy or breastfeeding

Quality Checklist

Good Signs

Vendor provides certificates of analysis (>98% purity)

Proper cold-chain shipping with ice packs/refrigeration

Vacuum-sealed vials showing pressure seal integrity

White/off-white lyophilized powder

Warning Signs

Verify expiration dates; lyophilized peptides stable ~2 years if stored properly

Bad Signs

Pre-reconstituted solutions—peptide degrades rapidly

Discolored powder (yellow/brown indicates degradation)

Cloudy solution after reconstitution

Frequently Asked Questions

How many times per day should CJC-1295 (without DAC) be injected?

CJC-1295 without DAC typically requires 2-3 injections daily (morning, post-workout optional, and bedtime) with 100-300mcg per dose to maintain GH elevation. The 30-minute to 2-hour half-life necessitates multiple daily injections, unlike the weekly DAC variant.

What time of day is best to inject CJC-1295 without DAC?

Optimal timing is upon waking on an empty stomach and before bedtime, with an optional post-workout injection. Inject 30+ minutes away from food to maximize GH release. Bedtime dosing is particularly effective as it amplifies natural sleep-associated GH pulses.

Does CJC-1295 without DAC maintain natural GH pulsatility unlike the DAC version?

Yes, the non-DAC version preserves natural pulsatile GH secretion patterns with its 30-minute half-life, whereas DAC provides continuous elevation. This pulsatility is closer to physiology and results in fewer side effects like joint pain compared to continuous DAC stimulation, making it popular for anti-aging protocols.

Can CJC-1295 be stacked with GHRP peptides for better results?

Yes, combining CJC-1295 without DAC with GHRP-6 or GHRP-2 creates a synergistic 'stack' where the GHRH and GHRP work through complementary pathways to amplify GH release significantly beyond either peptide alone. This is the classic approach for maximizing growth hormone stimulation.

References

Identified CJC-1295 as a tetrasubstituted hGRF(1-29) analog that covalently binds albumin. Showed 4-fold increase in GH area under the curve compared to native hGRF(1-29) in rat pituitary cells.

Single injection of CJC-1295 produced dose-dependent 2- to 10-fold increases in GH for 6+ days and 1.5- to 3-fold increases in IGF-I for 9-11 days in healthy adults. Estimated half-life of 5.8-8.1 days.

GH secretion was increased after CJC-1295 with preserved pulsatility. Basal (trough) GH levels were markedly increased (7.5-fold), demonstrating that CJC-1295 maintains natural GH pulse patterns.

Once-daily CJC-1295 maintained normal body composition and growth in GHRH knockout mice, demonstrating efficacy in restoring GH axis function in GH-deficient animal models.

CJC-1295 administration in normal adults activated the GH/IGF-1 axis and produced measurable serum protein profile changes, providing biomarker evidence for sustained GHRH analog activity.

Related Peptides

Complementary GH release via different receptor pathways. Popular combination.

Amplifies GH pulse when combined.

Potent combination maximizing GH through dual pathways.

Different mechanisms; continuous ghrelin versus pulsatile GHRH.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.

Connected topics

Follow this recovery question